|
|
|
|
|
|
|
|
|
|
The American Journal of Surgical Pathology - Abstract: Volume 32(11) November 2008 p 1667-1674 Subdividing Ovarian and Peritoneal Serous Carcinoma Into Moderately Differentiated and Poorly Differentiated
Subdividing Ovarian and Peritoneal Serous Carcinoma Into Moderately Differentiated and Poorly Differentiated Does not Have Biologic Validity Based on Molecular Genetic and In Vitro Drug Resistance Data.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.